Central Laboratories White Papers & Articles
-
The AI Revolution In Clinical Trials
11/13/2025
AI is reshaping clinical trials by accelerating patient recruitment, optimizing protocol design, and improving data quality—driving faster, more efficient, and more inclusive research outcomes.
-
The Answer To Your Pharmacovigilance Challenges: AI-Powered Adverse Event Detection
11/7/2025
A proven, AI-powered safety platform can accelerate adverse event detection and safety data extraction to ease the burden on safety professionals and better protect patients.
-
The Trust Deficit: Is An Overlooked Literacy Gap Stalling Clinical Trial Enrollment?
11/7/2025
Here, we examine the critical disconnect in a patient's understanding and how purpose-built AI platforms can translate complex medical language into plain, accessible communication.
-
How Emerging Technologies Are Challenging Traditional IRB Oversight
11/6/2025
Uncover how sponsors, CROs, and study monitors can navigate FDA expectations and Institutional Review Board (IRB) requirements when integrating AI and Software-as-a-Medical-Device into clinical trials.
-
How AI-Enhanced CAPA Systems Actually Work
11/6/2025
Learn how AI can accelerate root cause analysis, predict quality risks, and streamline CAPA without compromising compliance or overwhelming your team with practical strategies.
-
Unlock Efficiency And Compliance With Data Modernization Solutions
10/29/2025
Designed for leaders and professionals in the life sciences sector, this piece provides a practical framework for transforming data management into a catalyst for efficiency, compliance, and long-term innovation.
-
Wrangling Data With AI To Help Shape The Industry's Future
10/29/2025
Uncover how biotech firms can harness emerging technologies and other AI-driven innovations to shape the future of data-powered healthcare and scientific discovery.
-
Building Blocks: The Ultimate Guide To AI In Clinical Trials
10/29/2025
This comprehensive guide provides an authoritative, in-depth look at AI's role in accelerating drug development and improving patient outcomes, with special focus on emerging agentic AI technologies.
-
Sanofi's Take On The Evolving Role Of AI In Clinical Trials
10/29/2025
Matthew Peruhakal, Global Head of Data Architecture, Utilization, and AI Engineering at Sanofi, offers a deep look at how the pharmaceutical giant is integrating AI to transform clinical trials.
-
A New Take On The Evolving Role Of AI In Clinical Trials
10/29/2025
Artificial intelligence is shifting from promise to practice in biopharma. Zhong Lu, director of data science and AI at Novartis, outlines how AI is evolving the clinical trials process end-to-end.